SCHEMBL7991403

SCHEMBL7991403

CC(C)(C)c1ccc(Cn2cnc3[nH]c(-c4cccc(N)c4)nc(=O)c32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCC8 Q09428 1/20 0.43
▸ KCNJ11 Q14654 1/20 0.43
▸ NR1H4 Q96RI1 5/20 0.38
▸ CNOT7 Q9UIV1 2/20 0.38
▸ PARN O95453 1/20 0.38
▸ GNRHR P30968 2/20 0.35
▸ PNP P00491 1/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ TP53 P04637 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ SCN5A Q14524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985012 0.90 ABCC8 (0.43) ABCC8KCNJ11NR1H4CNOT7PARN
SCHEMBL7974282 0.89 ABCC8 (0.43) ABCC8KCNJ11NR1H4CNOT7PARN
SCHEMBL7992270 0.89 ABCC8 (0.43) ABCC8KCNJ11NR1H4CNOT7PARN
SCHEMBL7984427 0.89 HPGD (0.44) CNOT7PARNPNPKDM4ENPC1
SCHEMBL7974492 0.89 ABCC8 (0.47) ABCC8KCNJ11NR1H4CNOT7PARN
SCHEMBL7988017 0.89 KDM4E (0.43) ABCC8KCNJ11KDM4ENPC1ALDH1A1
SCHEMBL7984474 0.89 ABCC8 (0.42) ABCC8KCNJ11NR1H4CNOT7PARN
SCHEMBL7988524 0.88 ABCC8 (0.47) ABCC8KCNJ11NR1H4CNOT7PARN
SCHEMBL7984663 0.88 CNOT7 (0.49) CNOT7PARNPNPKDM4ENPC1
SCHEMBL7985602 0.88 SERPINE1 (0.45) ABCC8KCNJ11TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback